particularly for therapy of atherogenic dyslipidemia. A Kontush is a Senior Research Investigator in and MJ Chapman is Director of the Dyslipoproteinemia and Atherosclerosis Research Unit (U.
In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that provides stability ...
Cardiovascular diseases remain a leading cause of mortality globally, particularly among individuals with both obstructive sleep apnea (OSA) and metabolic syndrome (MetS).
Hyperuricemia (HU), characterized by elevated uric acid (UA) levels in the blood, is a global health concern associated with various conditions, including cardiovascular diseases, gout, hypertension, ...
Dyslipidemia, a risk factor for cardiovascular disease ... Some of the vascular events include peripheral artery disease, a condition in which narrowed arteries reduce blood flow to the arms or legs, ...
This new understanding could enhance future risk assessment and treatment strategies for patients with atherosclerosis. ‘Fat in the Arteries, Danger to the Heart: Atherosclerosis is the hidden ...